NCT06192472View on ClinicalTrials.gov

Investigation Into the Pathophysiology and Treatment of Varicose Veins

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

September 30, 2015

Conditions
Varicose Veins
Interventions
PROCEDURE

Chemical sclerotherapy

Sclerosant will be retained within the vein

DRUG

1% Sodium Tetradecyl Sulphate

1% Sodium Tetradecyl Sulphate

DRUG

3% Sodium Tetradecyl Sulphate

3% Sodium Tetradecyl Sulphate

DRUG

0.5% Polidocanol

0.5% Polidocanol

DRUG

3% Polidcanol

3% Polidcanol

Trial Locations (2)

GU2 7RF

The Whiteley Clinic, Guildford

GU2 7XH

University of Surrey, Guildford

All Listed Sponsors
collaborator

The Whiteley Clinic

OTHER

lead

University of Surrey

OTHER

NCT06192472 - Investigation Into the Pathophysiology and Treatment of Varicose Veins | Biotech Hunter | Biotech Hunter